Major trial confirms value of zoledronic acid dosed every 3 months in preventing pain, SREs

Posted on June 17, 2015 by Sitemaster

An interesting paper that we managed to miss at the recent annual meeting of the American Society of Clinical Oncology (ASCO) provided the results of a large, randomized clinical trial of the use of zoledronic acid, carried out by the Cancer and Leukemia Group B cooperative trial group. … READ MORE …

Filed under: Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: , , , , , , , | Leave a comment »

Skeletal complications and survival of HRPC patients

Posted on June 10, 2009 by Sitemaster

It is well understood that skeletal complications are a crucial factor in the quality of life and the prognosis of patients with hormone-refractory prostate cancer (HRPC); however, their true prevalence and impact on the prognosis remain largely unknown. … READ MORE …

Filed under: Management, Treatment | Tagged: , , , , | Leave a comment »

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives